14.6.2016 г.1 PHARMACOKINETICS OF ENROFLOXACIN IN DUCKS WITH STEATOSIS AFTER FORCE-FEEDING Neno Bratoev, Lubomir Lashev Department of Pharmacology, Physiology.

Slides:



Advertisements
Similar presentations
Treatment of hypertension in patients with peptic ulcer and liver pathology DM Leonid Lazebnik DM Leonid Lazebnik DM Olga Mikheeva The Central Research.
Advertisements

PHARMACOKINETIC MODELS
Instant Clinical Pharmacology E.J. Begg
PHARMACOKINETIC.
The half-life OCT 2010.
SEMINAR ON NONCOMPARTMENTAL PHARMACOKINETICS
Efficiency of different sources of Saccharomyces cerevisiae for decontamination of aflatoxin B 1 in Phosphate buffer saline solution Carlos Humberto Corassin,
Selected Clinical Calculations
Pharmacokinetics as a Tool
Selected bioavailability and pharmacokinetic calculations Dr. Osama A. A. Ahmed.
Pharmacokinetics of Drug Absorption
One-compartment open model: Intravenous bolus administration
Nieves Velez de Mendizabal 1, 2, Kimberley Jackson 3, Brian Eastwood 4, Steven Swanson 5, David M. Bender 5, Stephen Lowe 6, Robert R. Bies 1, 2 A Population.
Laplace transformation
Pharmacokinetics (PK): What the body does to the drug? Most drugs: Enter the body by crossing barriers Distributed by the blood to the site of action Biotransform.
Toxicokinetic Calculations
Gokaraju Rangaraju College of Pharmacy
INTRAVENOUS INFUSION.
VM 8314 Dr. Jeff Wilcke Pharmacokinetic Modeling (describing what happens)
Week 6- Bioavailability and Bioequivalence
Regulatory requirements Drs. Jan Welink Training workshop: Assessment of Interchangeable Multisource Medicines, Kenya, August 2009.
DEVELOPMENT OF A RP-HPLC METHOD FOR THE DETERMINATION OF METFORMIN IN HUMAN PLASMA.
Bioavailability Dr Mohammad Issa.
Drug Metabolism and Pharmacokinetics Core Goal: To provide comprehensive pharmacology support for preclinical and clinical research.
PHARMACOKINETIC MODELS
INJECTAFER Pharmacokinetics (PK) and Pharmacodynamics (PD) Christy S. John, Ph.D Division of Clinical Pharmacology V Office of Clinical Pharmacology Division.
Materials and Methods Phase 1 Evaluated acute effects on fasting blood glucose and on post-oral glucose Groups 1 and 3 received distilled water Groups.
Population Pharmacokinetic Characteristics of Levosulpiride and Terbinafine in Healthy Male Korean Volunteers Yong-Bok Lee College of Pharmacy and Institute.
Area under the plasma concentration time curve. IMPORTANCE OF AUC Pharmacokinetics - measurement of bioavaibility absolute, relative Biopharmaceutics.
Drug Administration Pharmacokinetic Phase (Time course of ADME processes) Absorption Distribution Pharmaceutical Phase Disintegration of the Dosage Form.
The effect of fluvoxamine on the pharmacokinetics, and safety of ivabradine in healthy subjects Adina Popa 1, Laurian Vlase 2, Maria Neag 3, Dana Muntean.
CHEE 4401 Definitions drug - any substance that affects the structure or functioning of an organism pharmaceutics - the area of study concerned with the.
Noncompartmental Models. Introduction The noncompartmental approach for data analysis does not require any specific compartmental model for the system.
Bioavailability Dr. Basavaraj K. Nanjwade M. Pharm., Ph. D Department of Pharmaceutics Faculty of Pharmacy Omer Al-Mukhtar University Tobruk, Libya.
Continuous intravenous infusion (one-compartment model)
Research Number (8). The in-vitro and in-vivo Evaluation of Tiamulin and Tilmicosin for the Treatment of Mycoplasma gallisepticum Infected Broiler Chickens.
INTRODUCTION CLINICAL PHARMACOKINETICS
1 Pharmacokinetics: Introduction Dr Mohammad Issa.
Examples of deficiencies in submitted data Drs. J. Welink Workshop on WHO prequalification requirements for reproductive health medicines, Jakarta, October.
Copyright ©2008 by Pearson Education, Inc. Upper Saddle River, New Jersey All rights reserved. Focus on Pharmacology, First Edition By Jahangir Moini.
Clinical Pharmacokinetic Equations and Calculations
GARLIC AND HEALTH in vivo Metabolism of DADS 4 th October 2001 Study of in vivo Diallyl disulfide Metabolism Aims of the study : –To determine the pharmacokinetic.
415 PHT Plasma Level – Time Curve
Determination of metformin in urine (by Liquid Chromatography LC)
Evaluation of quality and interchangeability of medicinal products - EAC/EC/WHO Training workshop / September |1 | Prequalification programme:
Definitions and Concepts
Source: Frank M. Balis Concentration and Effect vs. Time Conc./ Amount Effect [% of E MAX ] Time Central Compartment Peripheral Compartment Effect Compartment.
Drug Response Relationships
By Kavitha kannan, SBST. Liver is the most important and large glandular organ in human body that necessary for survival. The main functions are detoxification,
Metreleptin Drugbank ID :DB09046
Quantitation of 9 different coccidiostats in poultry using LC-MS/MS on a LCMS 8060 triple quadrupole Jana Rykl1; Ty Kahler2 1Shimadzu Switzerland GmbH,
Temocillin pharmacokinetics in healthy volunteers
Chapter 8 BIOAVAILABILITY & BIOEQUIVALENCE
Chapter 9 PHARMACOKINETICS VARIABILITY
Chapter 7 COMPARTMENT MODELS
Lecture-8 Biopharmaceutics
Pharmacokinetic Modeling (describing what happens)
COMPARATIVE TOXICITY STUDY OF CHLOROQUINE AND HYDROXYCHLOROQUINE ON ADULT ALBINO RATS M.A. El Shishtawy,K. Haidar Hassan .Department of Forensic Medicine.
Evaluation of the Efficacy of Intramuscular (IM) Administration of Ceftaroline (CPT) Against a Methicillin-Resistant Staphylococcus aureus (MRSA) Strain.
Chapter 1 Introduction to Biopharmaceutics & Pharmacokinetics
Agro Tech International Ltd. New Zealand
Quantitative Pharmacokinetics
Nucleic Acid Polymers with Accelerated Plasma and Tissue Clearance for Chronic Hepatitis B Therapy  Ingo Roehl, Stephan Seiffert, Celia Brikh, Jonathan.
Selected Bioavailability and Pharmacokinetic Calculations
1 Concentration-time curve
Pharmacokinetics/Pharmacodynamics
Nanoemulsions as Versatile Formulations for Paclitaxel Delivery: Peroral and Dermal Delivery Studies in Rats  Sateesh Khandavilli, Ramesh Panchagnula 
Levofloxacin structural formula
REFERENCE: APPLIED CLINICAL Slideshow by: lecturer HADEEL DELMAN
Presentation transcript:

г.1 PHARMACOKINETICS OF ENROFLOXACIN IN DUCKS WITH STEATOSIS AFTER FORCE-FEEDING Neno Bratoev, Lubomir Lashev Department of Pharmacology, Physiology and Physiological Chemistry, Faculty of Veterinary Medicine, Trakia University, 6000 Stara Zagora, Bulgaria Bulgaria

г.2Introduction Enrofloxacin (EFC) is second generation broad spectrum fluoroquinolone is developed for exclusive use in veterinary medicine, active against many Gram-positive and Gram-negative microorganisms. Its disposition has been studied in many avian species and some interspecies differences were pointed out. In the animals organism it is partly transformed to ciprofloxacin – also substance with high antimicrobial activity Although the opinion that when carried out according to professional standarts and on a small scale, force-feeding does not induce diet-related pathological changes, as the steatosis is reversible during this period the birds have changed physiology like increased body weight, triglyceridaemia, high ASAT and lipase blood levels. Such type of changes can define changes of the drug disposition in case of disease and necessary treatment The aim of our study was to investigate the pharmacokinetics of enrofloxacin and its main metabolite ciprofloxacin in force-fed ducks

г.3 Material and methods Animals Twelve 11-week-old male and female healthy ducks (sterile hybrid between male Muscovy ducks (Cairina moschata) and female Peking ducks (Anas platyrhynchos), weighing kg and twelve 13-weeks-old ducks of the same breed, but at the end of the force feeding, weighting kg were included in the experiment The animals were housed in groups of 6 birds each. During this period observations were carried out twice per day. Food and water were provided ad libitum. The food was withheld from 18 hours before treatment until 8 hours after it Drug Enrofloxacin hydrochloride 5% solution for i.v. injection (Baytril ® 5% injectable solution, Bayer Animal Health, Germany) was used. Oral treatment was made using the same solution after dilution with distilled water to concentration of 2.5%

г.4 Study design The ducks were allocated to four groups. Two groups (6 normal just before the fattening and 6 force-fed at the end of the period) were given a single i.v. dose of 10 mg/kg of b.w. in the right brachial vein. The other two groups containing 6 ducks each (not fed and at the end of the force fattening) were administered with the same dose enrofloxacin directly into the crop using a plastic tube attached to syringe. Blood samples (each of 1.0 ml) (without anticoagulant) were obtained from the left brachial vein at the times: after i.v. administration , 0.25, 0.5, 1, 3, 6, 9, 12, 18 and 24 h. and after p.o. administration , 0.5, 1, 3, 6, 9, 12, 18 and 24 hr. The samples were centrifuged for 15 minutes at 1800g. The obtained serum was stored at -20° C until analysis. Material and methods

г.5 Analytical method Plasma concentrations of enrofloxacin and its metabolite ciprofloxacin were assayed by a HPLC method. The system consisted on a Hipersil Spherisorb ODS-2(C18)-250 x 4.6- mm 5 µm column, a Surveyor LC Pump Plus, A Surveyor fluorescence detector, and a Surveyor Autosampler Plus (Thermo Fisher Scientific Inc., USA) The limit of quantification (LOQ) of EFL and CIP were found to be 0.01 µg mL-1. The limit of detection (LOD) was determined to be µg mL-1 for both compounds Pharmacokinetic analysis The pharmacokinetic analysis was carried out by specialized software WinNonlin (Pharsight, USA) Statistical analysis Descriptive statistics was performed with Statistica for Windows (Statistica 6.0.1, USA). Data were presented as mean ± SD

г.6 Results The followed biochemical parameters (ASAT, ALAT, LDH, Cholesterol, Bilirubin, Triglycerides), characteristic for the liver function, presented on the next slide show typical for steatosis findings - higher values compared to control birds

г.7 Results

г.8 Results

г.9 Results The serum concentrations after i.v. injection presented two- compartment model of distribution and elimination The oral administration was followed by a one-compartment of absorption and elimination

г.10 Table 1. Selected pharmacokinetic parameters (Mean±SD) of enrofloxacin in ducks after single i.v. injection at a dose of 10mg/kg t 1/2  (h) t 1/2  (h) k 10 (h -1 ) k 12 (h -1 ) Cl B (l/kg/h)Vss(l/kg) AUC 0-inf (  g/ml.h ) MRT(h) Beforefeeding4.28 ± ± ± ± ± ± ± ± 0.45 Afterfeeding5.80 ± ± ± ± ± ± ± ± 1.29 The force-fed birds show slower distribution, higher volume of distribution and longer elimination half life, respectively longer presence of enrofloxacin in the organism of the treated birds Results

г.11 Table 2. Selected pharmacokinetic parameters (Mean±SD) of enrofloxacin in ducks after single intraingluvial administration at a dose of 10mg/kg – compartment analysis. t 1/2abs (h) t 1/2el (h) AUC 0-inf (  g/ml.h) Tmax(h)Cmax (  g/ml) F(%) Beforefeeding0.46 ± ± ± ± ± AfterFeeding0.53 ± ± ± ± ± Results The absorption (t 1/2 abs ) of enrofloxacin in the force-fed ducks was slower Maximal serum concentrations (Cmax) and bioavailability (F) were higher in fattening ducks The elimination (t 1/2el ) is shorter in ducks after force-feeding

г.12 Table 3. Selected pharmacokinetic parameters (Mean  SD) of enrofloxacin and its metabolite ciprofloxacin in ducks after single intraingluvial administration at a dose of 10mg/kg – Noncompartment analysis Substance t 1/2 el (h) C max (  g/ml) T max (h) AUC 0-inf (  g/ml.h) MRT(h)F(% BeforefeedingEnrofloxacin7.42 ± ± ± ± Ciprofloxacin7.54 ± ± ± ± ± 2.35 AfterfeedingEnrofloxacin13.8 ± ± ± ± ± Ciprofloxacin21.59 ± ± ± ± ± 9.7 No significant difference between both groups using noncompartment analysis The bioavailability (F) was not influenced by feeding. The relations AUC cipro /AUC enro lead to the idea that metabolism of enrofloxacin in fed ducks is lower Results

г.13 Discussion The force-fed ducks distribute better enrofloxacin in the organism compared to normal ducks and eliminate it slower than in normally fed. The differences mentioned are not always statistically significant but could be a reason for longer enrofloxacin retention in force-fed ducks compared to normal The force-fed ducks distribute better enrofloxacin in the organism compared to normal ducks and eliminate it slower than in normally fed. The differences mentioned are not always statistically significant but could be a reason for longer enrofloxacin retention in force-fed ducks compared to normal The force-feeding does not affect significantly the oral enrofloxacin absorption, elimination and bioavailability. On the base of the CFC concentrations could be accepted that quality of metabolite is lower, respective the metabolism level is also lower The force-feeding does not affect significantly the oral enrofloxacin absorption, elimination and bioavailability. On the base of the CFC concentrations could be accepted that quality of metabolite is lower, respective the metabolism level is also lower

г.14 Conclusion The force-feeding of ducks can result in slower absorption, better distribution and slower elimination of enrofloxacin The force-feeding of ducks can result in slower absorption, better distribution and slower elimination of enrofloxacin The enrofloxacin bioavailability after oral administration and ciprofloxacin serum concentrations values are not significantly changed The enrofloxacin bioavailability after oral administration and ciprofloxacin serum concentrations values are not significantly changed

г.15 Thank you for attention !